Jetrea Articles

EU approval of Jetrea triggers a 45 million-euro milestone for ThromboGenics from Alcon

18 March 2013

Positive opinions for Novartis' Jetrea and Ilaris from EMA advisory panel

21 January 2013

ThromboGenics starts Jetrea roll-out in USA

15 January 2013

Fujifilm Diosynth to manufacture ocriplasmin for ThromboGenics

20 November 2012

US FDA approves ThromboGenics' Jetrea; advisory backing for Aegerion's lomitapide

19 October 2012

Ph III trials show Novartis' Jetrea improves vitreomacular traction

17 August 2012

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end